PATENT CLAIM ANALYSIS

Application Number: 15755484
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-02
Patent Classification: ["514", "261100"]

Abstract:
Pharmaceutical compounds, compositions, methods, and uses therefor are presented using selected triazolopyridines and triazolopyrimidines to inhibit or reduce phosphorylation of tau proteins or that act as antagonists of corticotropin-releasing factor. Viewed from another perspective, compounds, compositions, and methods are presented for treating or preventing symptoms of Alzheimer's disease by inhibiting or reducing the phosphorylation of tau proteins.

Claim (Index 2):
The compound of  claim 1 , wherein X is N.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 88.0
- Lexical Diversity: 1.5
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15548402', '13899985', '11873941', '12402910', '14009654']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7870794666570263
- 35 USC 102 Novelty (BERT): 0.5165447308149473
- Combined Prediction Score: 0.7600259930728185
- Mean Citation Score: 204.896344
- Max Citation Score: 296.67456
- Similarity Product: 204.1729874066162

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test